Dynamic Technology Lab Private Ltd purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 16,688 shares of the company's stock, valued at approximately $583,000.
Several other institutional investors and hedge funds have also recently made changes to their positions in OPCH. Northwestern Mutual Wealth Management Co. lifted its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares during the period. Brooklyn Investment Group boosted its stake in shares of Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after purchasing an additional 780 shares in the last quarter. Bessemer Group Inc. increased its holdings in Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after buying an additional 599 shares during the period. Public Employees Retirement System of Ohio raised its stake in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares in the last quarter. Finally, Wealthquest Corp purchased a new stake in Option Care Health during the first quarter worth $66,000. 98.05% of the stock is currently owned by institutional investors.
Option Care Health Stock Down 1.9%
Option Care Health stock opened at $28.70 on Thursday. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The business has a fifty day moving average price of $29.13 and a 200-day moving average price of $31.49. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The stock has a market capitalization of $4.66 billion, a price-to-earnings ratio of 22.96, a PEG ratio of 1.78 and a beta of 0.82.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm's revenue was up 15.4% compared to the same quarter last year. During the same period last year, the business posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on OPCH. JMP Securities lifted their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Option Care Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.
Read Our Latest Stock Report on OPCH
Insider Buying and Selling
In related news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the company's stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the transaction, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan purchased 20,000 shares of the firm's stock in a transaction on Thursday, August 21st. The stock was bought at an average cost of $27.51 per share, with a total value of $550,200.00. Following the acquisition, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 59,411 shares of company stock worth $1,627,576 in the last three months. Corporate insiders own 0.64% of the company's stock.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.